United States · Investor

Marshfield Associates

Last cheque observed Nov 2009. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

Series BVentureBusiness Information SystemsVoIPConsulting

Cheques on record
0%of best year0cheques in 12 months, 2 on record
Since the last cheque6180days00hrs00min00sec
Median round$1.0MRounds led0 of 2Exits1 from the portfolio
Pitch Marshfield Associates

Marshfield Associates highlights

  1. 01

    2 rounds on record

  2. 02

    Mostly Series B and Venture: 100% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Sectors
Business Information SystemsVoIPConsulting
Based in
Washington, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2009

    1 round

  2. Nov
    Biosystem DevelopmentVenture · US · freshnews.com$1.4MWith 4 others
  3. 2007

    1 round

  4. Nov
    Biosystem DevelopmentSeries B · US · wistechnology.com$600KWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration8 named

BEBrian Edward WalkerGeneral Counsel and Chief Compliance OfficeriForm ADV
CSCarolyn Sue MillerPrincipaliForm ADV
CAChad Andrew GoldbergPrincipaliForm ADV
CMChristopher Martin NiemczewskiPrincipaliForm ADV
EJElise Jordan HoffmannPrincipaliForm ADV
JGJudith Golden BeckerPrincipaliForm ADV
MVMelissa VinickPrincipaliForm ADV
WGWilliam Gilmore StottPrincipaliForm ADV

We also hold 32 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$8.1Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
Marshfield Associates, Inc.
SEC number
CRD 150614

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Biosystem DevelopmentBought by Agilent TechnologiesUndisclosedDec 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Marshfield Associates. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Marshfield Associates

What does Marshfield Associates invest in?

Marshfield Associates invests most often at Series B and Venture (100% of the rounds on record), in sectors such as Business Information Systems, VoIP and Consulting.

How active is Marshfield Associates?

2 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2009.

How big are Marshfield Associates's cheques?

The median round it joins is $1.0M.

Is Marshfield Associates investing now?

No investments in the last 12 months; the latest was in Nov 2009.

Who does Marshfield Associates invest alongside?

Most often Silicon Pastures (2 rounds together).

What kind of investor is Marshfield Associates?

Marshfield Associates is an investment firm based in Washington, United States.

How much does Marshfield Associates manage?

About $8.1B, as regulatory assets under management (Oct 2026).

When was Marshfield Associates founded?

Marshfield Associates was founded in 1989.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it